AIFA's restructuring in Italy aims to streamline drug approval, replacing committees and introducing...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreWe summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read moreOur market access experts provide an overview of how to get payer scientific advice between Septembe...
Read moreWe explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables ...
Read moreOur experts discuss the latest news and updates on the EU HTA process, including implications for ma...
Read moreOur clients have been developing new drugs for crowded, rapidly evolving therapy areas, with uncerta...
Read moreOncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read more